IBS
Published by NHC on
Irritable Bowel Syndrome (IBS)
Info
|
|
Description |
A functional bowel disorder charaterised by abdominal cramping/pain and altered bowel motions.
Three main subtypes:
|
Signs & Symptoms |
|
Causes & Contributors |
|
Pathophysiology/Aetiology |
Theories:
|
Treatment
|
|
Best Therapeutic Treatment |
*Find Underlying Cause and Treat Accordingly
1st Appointment
Nutritional
Dietary
Lifestyle
———————————————————————————-
2nd Appointment (Allow time for test results if needed)
*Please note treatment will be specific to the findings on pathology testing. These are general treatment options
Dietary
Consume These Often:
Avoid These:
Combination products
*Treatment of underlying causes will depend on test results.
|
Herbal |
|
Nutritional |
|
Dietary |
Consume These:
Avoid These:
*Give food swap ideas if necessary
|
Lifestyle |
|
Pharmaceutical |
|
Combination Products |
|
More
|
|
Differential Diagnosis |
|
Diagnostic Criteria |
ROME IV criteria
|
Testing/Examinations |
|
Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53(10):1459-1464. doi:10.1136/gut.2003.037697
Bone, K. (2007). The Ultimate Herbal Compendium. Phytotherapy Press
Braun, L., & Cohen, M. (2015). Herbs and Natural Supplements, Volume 2. Elsevier Health Sciences.
Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1285-1293. doi:10.1038/sj.bjp.0705762
Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1285-1293. doi:10.1038/sj.bjp.0705762
Hechtman, L. (2018). Clinical Naturopathic Medicine. Elsevier Health Sciences.
Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11(2):196-208. doi:10.5009/gnl16126
Jadallah KA, Nimri LF, Ghanem RA. Protozoan parasites in irritable bowel syndrome: A case-control study. World J Gastrointest Pharmacol Ther. 2017;8(4):201-207. doi:10.4292/wjgpt.v8.i4.201
Jadallah KA, Khader YS. Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study. World J Gastroenterol. 2009;15(42):5321-5325. doi:10.3748/wjg.15.5321
Manabe N, Tanaka T, Hata J, Kusunoki H, Haruma K. Pathophysiology underlying irritable bowel syndrome–from the viewpoint of dysfunction of autonomic nervous system activity. J Smooth Muscle Res. 2009;45(1):15-23. doi:10.1540/jsmr.45.15
Pedersen N, Andersen NN, Végh Z, et al. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol. 2014;20(43):16215-16226. doi:10.3748/wjg.v20.i43.16215Saadi M, McCallum RW. Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use. Ther Adv Chronic Dis. 2013;4(2):71-75. doi:10.1177/2040622312472008
Takakura W and Pimentel M (2020) Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front. Psychiatry 11:664. doi: 10.3389/fpsyt.2020.00664